-
Loading metrics
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- Hanyin Cheng,
- Lina Zhang,
- David E. Cogdell,
- Hong Zheng,
- Aaron J. Schetter,
- Matti Nykter,
- Curtis C. Harris,
- Kexin Chen,
- Stanley R. Hamilton,
- Wei Zhang
x
- Published: March 17, 2011
- https://doi.org/10.1371/journal.pone.0017745